Pascal Bamford - 01 Jun 2025 Form 4 Insider Report for Akoya Biosciences, Inc. (AKYA)

Role: Chief Clinical Officer
Signature: /s/ Pascal Bamford by Brian McKelligon, Attorney-in-Fact
Issuer symbol: AKYA
Transactions as of: 01 Jun 2025
Net transactions value: -$838
Form type: 4
Filing time: 02 Jun 2025, 17:52:39 UTC
Previous filing: 04 Mar 2025
Next filing: 10 Jul 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
BAMFORD PASCAL	Chief Clinical Officer	C/O AKOYA BIOSCIENCES, INC., 100 CAMPUS DRIVE, 6TH FLOOR, MARLBOROUGH	/s/ Pascal Bamford by Brian McKelligon, Attorney-in-Fact	02 Jun 2025	0002035474

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AKYA	Common Stock	Tax liability	$838	-670	-0.32%	$1.25	205,738	01 Jun 2025	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares withheld to cover taxes on a restricted stock unit award previously granted on May 18, 2023, which vests in four (4) annual equal installments beginning on June 1, 2024 and annually thereafter until fully vested.